@FierceBiotech: SEC hunting down traders who made a quick killing on Onyx shares. Report | Follow @FierceBiotech
@JohnCFierce: Orexo stakes out $500M market for new opioid-addiction drug. More | Follow @JohnCFierce
@RyanMFierce: Xoma staffers form biotech startup to advance blood pressure med. News | Follow @RyanMFierce
@EmilyMFierce: In case you missed it over the holiday... Scientists create first regulatory map of tuberculosis. Report | Follow @EmilyMFierce
> Fast on the heels of completing a discovery deal with Genentech, the U.K.'s Immunocore is expanding, adding 25 staffers and a new facility for their work. Story
> Theragenics has signed an agreement to get its brachytherapy seeds into Europe, in an effort to expand its market share as the company considers a buyout worth up to $71.4 million. Story
> The proxy outfit ISS has backed three of First Manhattan's 9 members nominatees to the board of Vivus ($VVUS), where First Manhattan is the largest shareholder and seeks greater control of the company's leadership. Report
> Paris-based Cellectis reported that the company's experimental T-cell therapy killed human leukemia cells that had been implanted in mice. Release
Medical Device News
@FierceMedDev: Europe tables vote on tougher device regs. More | Follow @FierceMedDev
@MarkHFierce: We want your FMD Fierce 15 nominations. Send them in! More | Follow @MarkHFierce
@DamianFierce: Theragenics has signed a deal to get its brachytherapy products on the market in the EU. Story | Follow @DamianFierce
@MichaelGFierce: ICYMI: Avanir drops $110M on novel inhaled-delivery migraine device. Article | Follow @MichaelGFierce
> India's move to modernize its medical device regulations appears close. More
> U.K. playing catch-up with proton-therapy devices. News
Pharma News
@FiercePharma: FDA to update generic labeling rules. Article | Follow @FiercePharma
@CarlyHFierce: ICYMI: Glass particles trigger another Fresenius Kabi recall. Story | Follow @CarlyHFierce
> Novartis' Lucentis gets its fourth approval in EU. News
> Orexo gets FDA approval for opioid addiction-fighting Zubsolv. Story
> Fresenius gets warning letter for India plant. More
Vaccines News
> Reliance on NIH threatens HIV vaccine funding. Story
> Polio discovery prompts Israeli vaccination push. More
> Merck KGaA: Lung cancer vaccine not dead. Article
> Study: Use of 2D barcodes could save healthcare $300M. News
> Novartis and Sanofi nab DoD vaccine contracts. Item
And Finally… ChemistDirect, a U.K. online pharmacy, has picked up $10 million in new investments from Atomico, Lepe Partners and DMG Media. Item